Anti-Snoring Devices Market Growth Opportunities and Forecast till 2030
The Global Anti-Snoring Devices Market Size valued for USD 2 Billion in 2021 and is anticipated to reach USD 4.9 Billion by 2030 with a CAGR of 10.6% from 2022 to 2030.
Negative pressure, a semi-collapse of the pharyngeal airway, and an obstruction of the upper airway are the causes of snoring. A soft or weak palate, an enlarged tongue, a deviated septum, nasal congestion, and swollen tonsils are additional factors.
Snoring is the name for the noise made when the uvula vibrates. It's made worse in particular by sleep apnea, a disorder in which people regularly stop breathing in the middle of the night due to blocked airways. Obstructive sleep apnea (OSA), a sleeping ailment frequently defined by its symptoms of snoring and choking during sleep, is treatable using a variety of dental equipment. As a result, they are occasionally referred to as anti-snoring devices.
Parameter |
Anti-Snoring Devices Market |
Anti-Snoring Devices Market Size in 2021 |
US$ 2 Billion |
Anti-Snoring Devices Market Forecast By 2030 |
US$ 4.9 Billion |
Anti-Snoring Devices Market CAGR During 2022 – 2030 |
10.6% |
Anti-Snoring Devices Market Analysis Period |
2018 - 2030 |
Anti-Snoring Devices Market Base Year |
2021 |
Anti-Snoring Devices Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Device Type, By Procedure, and By Region |
Anti-Snoring Devices Market Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Apnea Sciences Corporation, Tomed Dr. Toussaint GmbH, SomnoMed Ltd., Sleep Well Enjoy Life, Ltd., Fisher & Paykel Healthcare Limited, Sleeping Well, LLC, ResMed Inc. Koninklijke Philips NV, Airway Management, Inc., and MEDiTAS Ltd. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Anti-Snoring Devices Market Dynamics
The growing awareness of the negative health effects of snoring, the accessibility and benefits of anti-snoring treatments, the rise in the number of elderly and obese people, the prevalence of heavy alcohol and cigarette use, and the sizeable untapped snoring population are the main factors supporting the growth of this market. The creation of new Device Types by businesses and the use of cutting-edge R&D facilities are also creating several prospects for the growth of the global anti-snoring device market.
Oral appliances may result in discomfort, a feeling of a foreign body in the mouth, excessive salivation, or dry mouth. They are often used during a sleep study to determine the risk factors for OSAS, to diagnose it, if it is present, and to provide a baseline for tracking improvement with the use of the appliances. They provide a substitute for CPAP in many patients since they are reversible, easy to use, inexpensive, and efficient.
Because they require orthodontic expertise and are more expensive than fixed appliances, adjustable oral appliances. They are more time-consuming to make and take longer to acquire tolerance to, but they are more successful in lessening snoring in all OSAS patient types.
Anti-Snoring Devices Market Insights
Device type and surgical technique are used to segment the anti-snoring device market. The market is divided into categories according to device type, including continuous positive airway pressure (CPAP) devices, tongue stabilizing devices, and others. The market is segmented by surgical procedures into pillar procedure, somnoplasty, tonsillectomy, radiofrequency, uvulopalatopharyngoplasty (UPPP), and other surgical procedure.
Continuous positive airway pressure (CPAP) devices are predicted to hold the biggest market share in the anti-snoring device market by device type. CPAP is anticipated to maintain a CAGR of 10.5% within the device segment over the projection period. Air blockages call for the use of CPAP machines.
Global Anti-Snoring Devices Market Geographical Competition
The North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa regions make up the five geographical segments of the global Anti-Snoring Devices market. In 2021, North America is anticipated to control the market, and it is anticipated that it will continue to do so throughout the projected period. In the upcoming years, the market is expected to be driven by a number of factors, including increased availability of the most advanced anti-snoring devices, increased awareness of the dangers of airway obstruction, and more disposable income for the treatment of sleep disorders like snoring.
Due to rising home preferences and a large patient base that is being followed by a variety of population, the anti-snoring device market has enormous potential in the developing markets of Asia-Pacific. However, the Asia-Pacific market is anticipated to grow at the greatest CAGR throughout the projected period due to the region's developing middle class, escalating elderly population, and growing government assistance.
Global Anti-Snoring Devices Industry Segment Analysis
Anti-Snoring Devices Market By Device Type
· Mandibular Advancement Devices (MADs)
· Tongue Stabilizing Devices (TSDs)
· Continuous Positive Airway Pressure (CPAP) Devices
· Others
Anti-Snoring Devices Market By Procedure
· Somnoplasty
· Pillar Procedure
· Tonsillectomy
· Uvulopalatopharyngoplasty (UPPP)
· Radiofrequency
· Other Surgical Procedures
Anti-Snoring Devices Market Leading Companies
This section of the study honors the market's top vendors Apnea Sciences Corporation, Tomed Dr. Toussaint GmbH, SomnoMed Ltd., Sleep Well Enjoy Life, Ltd., Fisher & Paykel Healthcare Limited, Sleeping Well, LLC, ResMed Inc. Koninklijke Philips NV, Airway Management, Inc., and MEDiTAS Ltd.
Anti-Snoring Devices Market Regions
North America
· U.S.
· Canada
Europe
· U.K.
· Germany
· France
· Spain
· Rest of Europe
Latin America
· Brazil
· Mexico
· Rest of Latin America
Asia-Pacific
· China
· Japan
· India
· Australia
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· GCC
· South Africa
· Rest of Middle East & Africa